Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
A New Initiative on Precision MedicineThe New England journal of medicine, 2015-02, Vol.372 (9), p.793-795 [Peer Reviewed Journal]Copyright © 2015 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMp1500523 ;PMID: 25635347Full text available |
|
2 |
Material Type: Article
|
Cancer research needs a better mapNature (London), 2021-01, Vol.589 (7843), p.514-516 [Peer Reviewed Journal]COPYRIGHT 2021 Nature Publishing Group ;Copyright Nature Publishing Group Jan 28, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/d41586-021-00182-0 ;PMID: 33500573Full text available |
|
3 |
Material Type: Article
|
The Politics of Recruiting Dr. R Lee Clark Jr. as the First Permanent Director of The University of Texas MD Anderson Hospital for Cancer ResearchAnnals of surgical oncology, 2022-01, Vol.29 (1), p.733-749 [Peer Reviewed Journal]Society of Surgical Oncology 2021. ;ISSN: 1068-9265 ;EISSN: 1534-4681 ;DOI: 10.1245/s10434-021-10736-1Full text available |
|
4 |
Material Type: Article
|
The Politics of Recruiting Dr. R. Lee Clark Jr as the First Permanent Director of the University of Texas MD Anderson Hospital for Cancer ResearchAnnals of surgical oncology, 2022-01, Vol.29 (1), p.719-732 [Peer Reviewed Journal]Society of Surgical Oncology 2021. ;ISSN: 1068-9265 ;EISSN: 1534-4681 ;DOI: 10.1245/s10434-021-10735-2Full text available |
|
5 |
Material Type: Article
|
Common Sense Oncology: including everyone – Authors' replyThe lancet oncology, 2023-10, Vol.24 (10), p.e404-e404 [Peer Reviewed Journal]2023 Elsevier Ltd ;2023. Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(23)00464-3Full text available |
|
6 |
Material Type: Article
|
Survival at all costsNature (London), 2020-04, Vol.580 (7804), p.S1-S1 [Peer Reviewed Journal]Copyright Nature Publishing Group Apr 23, 2020 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/d41586-020-01038-9Full text available |
|
7 |
Material Type: Article
|
The Profile of Non-Communicable Disease (NCD) research in the Middle East and North Africa (MENA) region: Analyzing the NCD burden, research outputs and international research collaborationPloS one, 2020-04, Vol.15 (4), p.e0232077-e0232077 [Peer Reviewed Journal]COPYRIGHT 2020 Public Library of Science ;2020 Aggarwal et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Aggarwal et al 2020 Aggarwal et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0232077 ;PMID: 32339197Full text available |
|
8 |
Material Type: Article
|
Genetics and Pathogenesis of Diffuse Large B-Cell LymphomaThe New England journal of medicine, 2018-04, Vol.378 (15), p.1396-1407 [Peer Reviewed Journal]Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;(c) Massachusetts Medical Society, 2018 info:eu-repo/semantics/openAccess ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1801445 ;PMID: 29641966Full text available |
|
9 |
Material Type: Article
|
Mathematical Models of Cancer: When to Predict Novel Therapies, and When Not toBulletin of mathematical biology, 2019-10, Vol.81 (10), p.3722-3731 [Peer Reviewed Journal]The Author(s) 2019 ;ISSN: 0092-8240 ;EISSN: 1522-9602 ;DOI: 10.1007/s11538-019-00640-xDigital Resources/Online E-Resources |
|
10 |
Material Type: Article
|
Metabolomics in cancer research and emerging applications in clinical oncologyCA: a cancer journal for clinicians, 2021-07, Vol.71 (4), p.333-358 [Peer Reviewed Journal]2021 The Authors. published by Wiley Periodicals LLC on behalf of American Cancer Society ;2021 The Authors. CA: A Cancer Journal for Clinicians published by Wiley Periodicals LLC on behalf of American Cancer Society. ;Copyright Wiley Subscription Services, Inc. Jul/Aug 2021 ;ISSN: 0007-9235 ;EISSN: 1542-4863 ;DOI: 10.3322/caac.21670 ;PMID: 33982817Full text available |
|
11 |
Material Type: Article
|
Preclinical mouse solid tumour models: status quo, challenges and perspectivesNature reviews. Cancer, 2017-12, Vol.17 (12), p.751-765 [Peer Reviewed Journal]COPYRIGHT 2017 Nature Publishing Group ;COPYRIGHT 2017 Nature Publishing Group ;Copyright Nature Publishing Group Dec 2017 ;ISSN: 1474-175X ;EISSN: 1474-1768 ;DOI: 10.1038/nrc.2017.92 ;PMID: 29077691Full text available |
|
12 |
Material Type: Article
|
Olfactory receptors are not unique to the noseNature (London), 2022-06, Vol.606 (7915), p.S14-S17 [Peer Reviewed Journal]ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/d41586-022-01631-0Full text available |
|
13 |
Material Type: Article
|
Integrating gender into cancer researchThe Lancet (British edition), 2024-04, Vol.403 (10437), p.1631-1631 [Peer Reviewed Journal]2024 Elsevier Ltd ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00593-2 ;PMID: 38677852Full text available |
|
14 |
Material Type: Article
|
Precision Medicine: From Science To ValueHealth Affairs, 2018-05, Vol.37 (5), p.694-701 [Peer Reviewed Journal]Copyright The People to People Health Foundation, Inc., Project HOPE May 2018 ;ISSN: 0278-2715 ;EISSN: 1544-5208 ;EISSN: 2694-233X ;DOI: 10.1377/hlthaff.2017.1624 ;PMID: 29733705Full text available |
|
15 |
Material Type: Article
|
Cancer Cell Lines Are Useful Model Systems for Medical ResearchCancers, 2019-08, Vol.11 (8), p.1098 [Peer Reviewed Journal]2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2019 by the authors. 2019 ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers11081098 ;PMID: 31374935Full text available |
|
16 |
Material Type: Article
|
A gut reaction can tune tumour fate during chemotherapyNature (London), 2023-03, Vol.615 (7950), p.36-37 [Peer Reviewed Journal]ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/d41586-023-00476-5 ;PMID: 36814015Full text available |
|
17 |
Material Type: Article
|
The future of liquid biopsyNature (London), 2020-03, Vol.579 (7800), p.S9-S9 [Peer Reviewed Journal]COPYRIGHT 2020 Nature Publishing Group ;COPYRIGHT 2020 Nature Publishing Group ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/d41586-020-00844-5 ;PMID: 32214259Full text available |
|
18 |
Material Type: Article
|
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaborationPLoS medicine, 2012-05, Vol.9 (5), p.e1001216-e1001216 [Peer Reviewed Journal]COPYRIGHT 2012 Public Library of Science ;COPYRIGHT 2012 Public Library of Science ;2012 Altman et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Altman DG, McShane LM, Sauerbrei W, Taube SE (2012) Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration. PLoS Med 9(5): e1001216. doi:10.1371/journal.pmed.1001216 ;Altman et al. 2012 ;ISSN: 1549-1676 ;ISSN: 1549-1277 ;EISSN: 1549-1676 ;DOI: 10.1371/journal.pmed.1001216 ;PMID: 22675273Full text available |
|
19 |
Material Type: Article
|
Stakeholders welcome proposal on the European Health Data SpaceThe lancet oncology, 2022-12, Vol.23 (12), p.1492-1492 [Peer Reviewed Journal]2022 Elsevier Ltd ;2022. Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(22)00691-X ;PMID: 36335972Full text available |
|
20 |
Material Type: Article
|
Retraction Note: Isovitexin reduces carcinogenicity and stemness in hepatic carcinoma stem-like cells by modulating MnSOD and FoxM1Journal of experimental & clinical cancer research, 2022-08, Vol.41 (1), p.1-263, Article 263 [Peer Reviewed Journal]COPYRIGHT 2022 BioMed Central Ltd. ;2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;BioMed Central_BMCE 2022 ;ISSN: 1756-9966 ;ISSN: 0392-9078 ;EISSN: 1756-9966 ;DOI: 10.1186/s13046-022-02470-7 ;PMID: 36038923Full text available |